Skip to Main Content

Paper Details

Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
9
2023
Author NameAffiliation
Heather H ChengUniversity of Washington
Heather H ChengClinical Research Division, Fred Hutchinson Cancer Center
Elahe A MostaghelUniversity of Washington
Elahe A MostaghelClinical Research Division, Fred Hutchinson Cancer Center
Elahe A Mostaghel
Michael C HaffnerClinical Research Division, Fred Hutchinson Cancer Center
Michael C HaffnerFred Hutchinson Cancer Center
Michael C HaffnerUniversity of Washington
Bruce MontgomeryUniversity of Washington
Bruce MontgomeryClinical Research Division, Fred Hutchinson Cancer Center
Bruce Montgomery
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Center
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Center
Evan Y YuUniversity of Washington
Evan Y YuClinical Research Division, Fred Hutchinson Cancer Center
  • 1 - 17

Datasets

Release 1.2